Ironwood Pharmaceuticals Inc
IRWD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001446847
In the last 90 days, Ironwood Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 212 institutions reported holding it in 13F filings for Q2 2026, worth $675.8M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Ironwood Pharmaceuticals Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 155
- −45 vs. Q1 2025
- Shares held
- 146.2M
- −9.26M (−6.0%) vs. Q1 2025
- Total value
- $104.9M
- −$123.6M (−54.1%) vs. Q1 2025
- New holders
- 19
- 60 more added
- Sold out
- 64
- 51 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRWD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $675.8M |
| Q1 2026 | 227 | $566.8M |
| Q4 2025 | 199 | $520.2M |
| Q3 2025 | 166 | $194.9M |
| Q2 2025 | 155 | $104.9M |
| Q1 2025 | 200 | $228.5M |
| Q4 2024 | 223 | $727.5M |
| Q3 2024 | 221 | $673.7M |
| Q2 2024 | 227 | $1.12B |
| Q1 2024 | 261 | $1.50B |
| Q4 2023 | 251 | $1.89B |
| Q3 2023 | 249 | $1.56B |
| Q2 2023 | 252 | $1.77B |
| Q1 2023 | 255 | $1.74B |
| Q4 2022 | 250 | $2.08B |
| Q3 2022 | 245 | $1.76B |
| Q2 2022 | 240 | $2.02B |
| Q1 2022 | 221 | $2.09B |
| Q4 2021 | 212 | $2.00B |
| Q3 2021 | 229 | $2.32B |
| Q2 2021 | 209 | $2.25B |
| Q1 2021 | 210 | $1.91B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Ironwood Pharmaceuticals Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Great West Life Assurance Co | 0 | $0 | 0.00% | −13,282−100.0% | Sold out |
| Farringdon Capital, Ltd. | 0 | $0 | 0.00% | −13,468−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −12,612−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −6,699−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −2,652−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −1,573−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −1,043−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −725−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −698−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −808−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −306−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Private Wealth Asset Management, LLC | 0 | $0 | 0.00% | −209−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −60−100.0% | Sold out |